January 5, 2024
- January 25, 2021 - NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed). See NOFO PAR-21-114.
National Institute of Neurological Disorders and Stroke (NINDS)
This Notice informs potential applicants that the Key Dates information listed in Notice of Funding Opportunity (NOFO) PAR-21-114, “NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)” has changed. Specifically, the expiration date has been changed from January 6, 2024 to April 6, 2024.
The Key Dates information listed under Part 1. Overview Information of PAR-21-114 was modified as follows:
Key Dates
Previously Read:
Posted Date: January 25, 2021
Open Date (Earliest Submission Date): March 05, 2021
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): Standard dates apply
The first standard due date for this FOA is April 5, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s): Not Applicable
*** SBIR/STTR applications are no longer accepted on Standard AIDS Due dates.
Scientific Merit Review: Standard dates apply
Advisory Council Review: Standard dates apply
Earliest Start Date: Standard dates apply
Expiration Date: January 06, 2024
Due Dates for E.O. 12372: Not Applicable
Revised to Read (changes shown in bold italics):
Posted Date: January 25, 2021
Open Date (Earliest Submission Date): March 05, 2021
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): Standard dates apply
The first standard due date for this FOA is April 5, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s): Not Applicable
*** SBIR/STTR applications are no longer accepted on Standard AIDS Due dates.
Scientific Merit Review: Standard dates apply
Advisory Council Review: Standard dates apply
Earliest Start Date: Standard dates apply
Expiration Date: April 06, 2024
Due Dates for E.O. 12372: Not Applicable
All other aspects of the NOFO remain unchanged.
Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1778
Email: Emily.caporello@nih.gov
and Human Services (HHS)
